Rhythm Pharmaceuticals buy Morgan Stanley
Start price
25.09.25
/
50%
€83.00
Target price
25.09.26
-
Performance (%)
-11.45%
Price
16.04.26
€73.50
Summary
This prediction is currently active. The price of Rhythm Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.45%. This prediction currently runs until 25.09.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 0.685% | 0.685% |
| iShares Core DAX® | 0,79 % | 1,97 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % |
| iShares S&P 500 | 2,50 % | 2,76 % |
Comments by Morgan_Stanley for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Morgan_Stanley for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
17.03.26
17.03.26
€118.29
17.03.27
17.03.27
-3.87%
16.04.26
16.04.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€100.00
11.12.25
11.12.25
-
11.12.26
11.12.26
-25.50%
16.04.26
16.04.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€95.00
16.10.25
16.10.25
€110.50
16.10.26
16.10.26
-21.58%
16.04.26
16.04.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€74.50
11.07.25
11.07.25
€81.37
11.07.26
11.07.26
0.00%
16.04.26
16.04.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€46.80
07.03.25
07.03.25
€66.38
07.03.26
07.03.26
67.74%
08.03.26
08.03.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€42.40
19.12.23
19.12.23
€50.16
19.12.24
19.12.24
30.90%
20.12.24
20.12.24